Treatment targeted at a genetic mutation relieves psychosis symptoms

Treatment of psychosis can be targeted to a specific genetic mutation in patients with psychotic disorders. The study provides a proof-of-principle demonstration that treatments can be tailored to a specific genotype, rather than diagnosis, to relieve symptoms. The findings also link an individual structural mutation to the underlying biology of psychosis and treatment response.